Healthtech Startups

Tuned offers online hearing health services for employers, providing screenings, virtual audiology consultations, and discounted or fully-covered hearing aids and related solutions across multiple plan tiers.

1 investor

TURN Community Services is Utah's largest non-profit provider of disability services, supporting over 850 individuals with developmental disabilities through residential programs, day services, employment support, and community activities. The organization serves individuals across Utah with a mission to build community through respect, dignity, and opportunity.

1 investor

TurningMode develops medical technologies for healthcare providers including smart illumination systems, patient ventilation solutions, and sterilization technology. The company aims to improve clinical workflows and patient care outcomes for physicians, nurses, and caregivers.

1 investor

TurnUp builds healthcare scheduling software that reduces no-shows, cancellations, and empty appointment slots so care providers can fill gaps and patients on waiting lists receive care sooner. It targets healthcare practices and care providers.

1 investor

Roche develops diagnostics and pharmaceutical medicines to address major healthcare challenges and improve patient outcomes across prevention, treatment, and cure.

1 investor

TuuthFairy provides a GraphQL API that gives dental software platforms access to insurance data from hundreds of dental carriers, including plan maximums, deductibles, benefits, and frequency limitations. It targets dental software companies and developers with webhook-based real-time updates and SOC 2 compliance.

1 investor

Tuyo Health is a telehealth service led by Latino, board-certified physicians offering care in the patient's chosen language, serving Spanish-speaking and Latino patients in the United States. It provides primary care memberships and specialty programs such as weight loss (GLP-1), men's sexual health, testosterone therapy, birth control, and hair loss without requiring insurance.

1 investor

1 investor

Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases. Its pipeline includes TTI-101, a direct STAT3 inhibitor in a Phase 2 trial for hepatocellular carcinoma, and TTI-109, a phosphate prodrug of TTI-101.

1 investor

Twenty30 Health provides a platform offering multimodal, whole-person care for people living with obesity and related metabolic conditions in the US. It sells to employers, health systems, payers, TPAs, and brokers as a way to manage metabolic health costs and improve patient outcomes.

1 investor

Twenty Two develops AI-powered biosecurity infrastructure for screening and monitoring biological threats across the emerging bioeconomy. The platform provides automated customer screening, functional sequence prediction, and model safeguards to help organizations comply with dual-use research regulations.

1 investor

Twig Fertility provides guidance, service, technology, and support to couples navigating the fertility treatment journey. The company aims to improve the patient experience within fertility clinics by offering comprehensive hand-holding and education throughout the process.

1 investor

Twill provides digital health products including community platforms, wellness applications, and mental health tools for chronic condition management. The platform serves patients and individuals seeking mental health support and wellness resources across multiple languages.

1 investor

Twinn Health provides preventive whole-body MRI infrastructure, offering AI-structured reporting and longitudinal health data for imaging providers and wellness clinics, plus expert MRI interpretation support for individuals. Originating from research at Imperial College London, it focuses on early disease detection in emerging longevity markets across the UK and the Middle East.

1 investor

Twilight develops injectable precision immunotherapies to train the body's immune system to treat chronic diseases at scale. The company targets conditions that existing therapies inadequately address, with a focus on neurological and immunological diseases.

1 investor

TWO is a health and wellness company that aims to inspire behavioral change toward healthier lifestyles through scientific and ethical communication. The company pursues "true health" aligned with environmental and social responsibility, targeting individuals seeking better nutrition, fitness, and sleep habits.

1 investor

Ask Twofold is an AI clinician assistant built into Twofold's clinical platform that helps healthcare providers with clinical documentation, referral letters, billing and coding support, and compliance preparation through conversational natural language. The tool serves mental and behavioral health providers, psychiatrists, psychologists, therapists, social workers, and other clinicians in solo practices, group practices, and clinics.

1 investor

Twoje Znamiona operates a Poland-wide network of clinics specialized in skin lesion diagnostics, offering videodermatoscopy exams, surgical removal, histopathology, and oncology consultation under a single care pathway. The service uses proprietary software and a certified AI system to support physicians, and serves patients across eight cities in Poland.

1 investor

A HIPAA-compliant texting platform that enables secure communication between healthcare providers and patients, featuring encrypted messaging, data protection, and care coordination tools.

1 investor

Tympanogen develops Perf-Fix, a gel patch system for nonsurgical eardrum (tympanic membrane) repair that replaces traditional tympanoplasty with a clinic-based procedure. The product is aimed at ENT surgeons and clinicians for outpatient otologic care and is currently in development.

1 investor

Tympany Medical develops single-use variable-angle endoscopy technology for minimally invasive surgical procedures, aimed at improving patient outcomes and procedure times for medical professionals. The company emphasizes sustainable product development through reduced material use and waste.

1 investor

Type One Style is a UK-based direct-to-consumer company that designs and manufactures diabetes care products and accessories, with a focus on mental health support and community for people with diabetes. The company produces all goods in-house and sells globally, combining product innovation with content and community building.

1 investor

Typewriter Therapeutics develops mRNA-based gene therapies using a platform for targeted insertion of therapeutic genes, building on transposon research from the University of Tokyo. It aims to treat patients with severe genetic disorders, with research facilities in Tokyo and Cambridge, USA.

1 investor

Tyris Therapeutics develops non-viral gene therapies using a proprietary DNA format (oDNA™) to treat rare and prevalent genetic diseases. The company aims to provide safer, controllable treatments that can accommodate genes of any size, with the ability to adjust dosing and allow for retreatment.

1 investor